ÂÜÀòÂÒÂ×

Fabrizio Cacace is an experienced professional in pharmacovigilance and quality assurance, currently serving as Manager of Global Pharmacovigilance Quality Assurance at Alnylam Pharmaceuticals since November 2021. Prior to this role, Fabrizio worked as a Pharmacovigilance QA Consultant & Auditor at PQE Group, where responsibilities included conducting GVP audits and enhancing PV Quality Systems. Fabrizio's earlier experience includes serving as a Pharmacovigilance Quality Assurance Officer and Pharmacovigilance Officer at Di Renzo Regulatory Affairs, focusing on quality procedures, management of audits, and safety signal detection. Fabrizio began the career as a Junior Research Scientist at Fondazione Santa Lucia, contributing to neuroscience projects. Academic credentials include a Master of Science in Preclinical and Clinical Drug Development and Neurobiology, alongside a Bachelor of Science in Biological Sciences.